CTSG-expressing mast cells confer resistance to immunotherapy in colorectal cancer - Top-Institutions - MDSpire

CTSG-expressing mast cells confer resistance to immunotherapy in colorectal cancer

  • By

  • Xuehui Jiang

  • Runsheng Hong

  • Zilin Liu

  • Chao Zhong

  • Yun Dai

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Peking University First Hospital
    Peking University First Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #2

    The Jackson Laboratory
    The Jackson Laboratory

    Bar Harbor, Maine

    Key Differentiators

    • Oncology

  • #3

    National Infrastructure of Cell Line Resource
    National Infrastructure of Cell Line Resource

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #4

    Center for Cancer Immune Therapy, Herlev Hospital
    Center for Cancer Immune Therapy, Herlev Hospital

    Herlev, Copenhagen

    Key Differentiators

    • Oncology

  • #5

    Herlev and Gentofte Hospital Research Council
    Herlev and Gentofte Hospital Research Council

    Herlev, Copenhagen

    Key Differentiators

    • Oncology

Original Source(s)

CTSG-expressing mast cells confer resistance to immunotherapy in colorectal cancer

  • by Xuehui Jiang, Runsheng Hong, Zilin Liu, Chao Zhong, Yun Dai

  • July 1, 2026

Related Content

Comparative accuracy of spectral computed tomography and conventional computed tomography in colorectal cancer staging

NAFLD-associated immune remodeling in colorectal cancer liver metastasis: mechanisms and implications for immunotherapy

Development and expert radiologist validation of a custom pipeline for simplification of oncology radiology reports using large language model